Advertisement

Topics

IntelliPharmaCeutics Corp. Company Profile

00:59 EST 20th November 2017 | BioPortfolio


News Articles [134 Associated News Articles listed on BioPortfolio]

Intellipharmaceutics Receives Complete Response Letter from the FDA for Rexista NDA

TORONTO, Sept. 25, 2017 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the res...

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In IntelliPharmaCeutics International Inc. To Contact The Firm

NEW YORK, NY / ACCESSWIRE / September 6, 2017 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in IntelliPharmaCeutics International Inc. ('IntelliPharmaCeutics' or...

Pomerantz LLP: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of IntelliPharmaCeutics International Inc. - (IPCI)

NEW YORK, NY / ACCESSWIRE / July 27, 2017 / Pomerantz LLP is investigating claims on behalf of investors of IntelliPharmaCeutics International Inc. ("IntelliPharmaCeutics" or the "Company") (NASDAQ...

FDA committees set review date for Intellipharmaceutics' opioid drug

Intellipharmaceutics' Rexista, an opioid analgesic for moderate to severe pain, will be reviewed by the FDA's Anesthetic and  -More- 

IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against IntelliPharmaCeutics International Inc. and Reminds Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / August 15, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against IntelliPharmaCeutics International Inc. ("IntelliPharmaCeutics" o...

DEADLINE APPROACHING: Lundin Law PC Announces Securities Class Action Lawsuit against IntelliPharmaCeutics International Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / September 15, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against IntelliPharmaCeutics International Inc. ("IntelliPharmaCeutics...

EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against IntelliPharmaCeutics International Inc. and Reminds Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / August 31, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against IntelliPharmaCeutics International Inc. ("IntelliPharmaCeutics" o...

UPCOMING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against IntelliPharmaCeutics International Inc. and Reminds Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / September 7, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against IntelliPharmaCeutics International Inc. ("IntelliPharmaCeutics"...

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Feasibility of a Minimally Invasive Thoracoscopic Ultrasound for Localization of Pulmonary Nodules

The ex-vivo lung will be evaluated by XLTF-UC180 for localization of the tumor. The ultrasound probe will be put on the lung surface in several different directions to obtain the cross sec...

More Information about "IntelliPharmaCeutics Corp." on BioPortfolio

We have published hundreds of IntelliPharmaCeutics Corp. news stories on BioPortfolio along with dozens of IntelliPharmaCeutics Corp. Clinical Trials and PubMed Articles about IntelliPharmaCeutics Corp. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of IntelliPharmaCeutics Corp. Companies in our database. You can also find out about relevant IntelliPharmaCeutics Corp. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record